Fabry Disease Treatment Market
Alpha-galactosidase-related disease, often known as Fabry Disease Treatment Market- A shortage of the enzyme galactosidase A results in a deficit, an X-linked, hereditary lysosomal storage disorder (an enzyme required to metabolise lipids, fat-like substances that include oils, waxes, and fatty acids). The altered gene causes the body's many systems, including the autonomic nervous system, cardiovascular system, eyes, and kidneys, to produce dangerous amounts of lipids. Chronic pain, acroparesthesia, gastrointestinal issues, distinctive skin lesions (angiokeratomas), gradual renal failure, cardiomyopathy, and stroke are a few of the symptoms that are frequently present with this multisystem condition.
